tiprankstipranks
Alkermes initiates Phase 2 clinical trial of ALKS 2680
PremiumThe FlyAlkermes initiates Phase 2 clinical trial of ALKS 2680
25d ago
Alkermes price target lowered to $23 from $25 at UBS
PremiumThe Fly
Alkermes price target lowered to $23 from $25 at UBS
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
Alkermes’ ALKS 2680 improves wakefulness in Phase 1b narcolepsy study
PremiumThe FlyAlkermes’ ALKS 2680 improves wakefulness in Phase 1b narcolepsy study
1M ago
Alkermes presents results from long-term safety study of LYBALVI
PremiumThe Fly
Alkermes presents results from long-term safety study of LYBALVI
1M ago
Alkermes management to meet with Piper Sandler
PremiumThe Fly
Alkermes management to meet with Piper Sandler
2M ago
Alkermes downgraded to Sell from Neutral at UBS
PremiumThe FlyAlkermes downgraded to Sell from Neutral at UBS
3M ago
Alkermes price target raised to $33 from $30 at BofA
PremiumThe Fly
Alkermes price target raised to $33 from $30 at BofA
3M ago
Alkermes price target raised to $39 from $35 at Piper Sandler
PremiumThe Fly
Alkermes price target raised to $39 from $35 at Piper Sandler
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100